Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Status:
RECRUITING
Trial end date:
2027-05-26
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of single- and multiple-dose administration of S-892216-LAI in healthy adults.